RECALL ALERT: Recall issued for birth control pill TAYTULLA due to out of sequence capsules

FDA officials announced Tuesday that Allergan plc has issued a voluntary recall of a lot of their TAYTULLA birth control pills, due to the pulls being placed out of sequence.

According to a statement, FDA officials say the four placebo capsules had been placed out of order in a sample pack of TAYTULLA. In particular, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. Contraceptives that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy. Reversing the order may not be apparent to either new users or previous users of the product, thus increasing the likelihood of the pills being taken out of order.

The pills in question, according to the FDA, belong to lot 5620706, with an expiry date of May 2019.

Allegan is notifying customers by recall letter, and is arranging for the return of all recalled sample pack product.

Recall information